APP and Alzheimer disease: Caspase activation was reported to be upregulated early in AD progression (Gastard et al. 2003, Cribbs et al. 2004) and recently it was shown that increased caspase-3 activation is detectable in the absence of cell death in one APP transgenic mouse line (D’Amelio et al. 2011).